» Articles » PMID: 38398170

The Microbiome Modulates the Immune System to Influence Cancer Therapy

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2024 Feb 24
PMID 38398170
Authors
Affiliations
Soon will be listed here.
Abstract

The gut microbiota composition can affect the tumor microenvironment and its interaction with the immune system, thereby having implications for treatment predictions. This article reviews the studies available to better understand how the gut microbiome helps the immune system fight cancer. To describe this fact, different mechanisms and approaches utilizing probiotics to improve advancements in cancer treatment will be discussed. Moreover, not only calorie intake but also the variety and quality of diet can influence cancer patients' immunotherapy treatment because dietary patterns can impair immunological activities either by stimulating or suppressing innate and adaptive immunity. Therefore, it is interesting and critical to understand gut microbiome composition as a biomarker to predict cancer immunotherapy outcomes and responses. Here, more emphasis will be given to the recent development in immunotherapies utilizing microbiota to improve cancer therapies, which is beneficial for cancer patients.

Citing Articles

Microbiome Integrity Enhances the Efficacy and Safety of Anticancer Drug.

Mafe A, Busselberg D Biomedicines. 2025; 13(2).

PMID: 40002835 PMC: 11852609. DOI: 10.3390/biomedicines13020422.


Modulation of Intestinal Flora: a Novel Immunotherapeutic Approach for Enhancing Thyroid Cancer Treatment.

Huang W, Jiang T, He J, Ruan J, Wu B, Tao R Probiotics Antimicrob Proteins. 2025; .

PMID: 39890752 DOI: 10.1007/s12602-025-10471-z.


Consumption of a Probiotic Blend with Vitamin D Improves Immunity, Redox, and Inflammatory State, Decreasing the Rate of Aging-A Pilot Study.

Felix J, Baca A, Taboada L, Alvarez-Calatayud G, De la Fuente M Biomolecules. 2024; 14(11).

PMID: 39595538 PMC: 11591724. DOI: 10.3390/biom14111360.

References
1.
Yiannakou I, Singer M, Jacques P, Xanthakis V, Ellison R, Moore L . Adherence to a Mediterranean-Style Dietary Pattern and Cancer Risk in a Prospective Cohort Study. Nutrients. 2021; 13(11). PMC: 8622098. DOI: 10.3390/nu13114064. View

2.
Golkhalkhali B, Rajandram R, Paliany A, Ho G, Wan Ishak W, Johari C . Strain-specific probiotic (microbial cell preparation) and omega-3 fatty acid in modulating quality of life and inflammatory markers in colorectal cancer patients: a randomized controlled trial. Asia Pac J Clin Oncol. 2017; 14(3):179-191. DOI: 10.1111/ajco.12758. View

3.
Sfanos K, Markowski M, Peiffer L, Ernst S, White J, Pienta K . Compositional differences in gastrointestinal microbiota in prostate cancer patients treated with androgen axis-targeted therapies. Prostate Cancer Prostatic Dis. 2018; 21(4):539-548. PMC: 6283851. DOI: 10.1038/s41391-018-0061-x. View

4.
Pushalkar S, Hundeyin M, Daley D, Zambirinis C, Kurz E, Mishra A . The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression. Cancer Discov. 2018; 8(4):403-416. PMC: 6225783. DOI: 10.1158/2159-8290.CD-17-1134. View

5.
Key T, Bradbury K, Perez-Cornago A, Sinha R, Tsilidis K, Tsugane S . Diet, nutrition, and cancer risk: what do we know and what is the way forward?. BMJ. 2020; 368:m511. PMC: 7190379. DOI: 10.1136/bmj.m511. View